Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Completed 12Unknown 5Recruiting 4Not yet recruiting 3Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 54Other hematologic neoplasm 28Breast 27Gastrointestinal 24Thoracic 23Lymphoid 21Genitourinary 14Gynecologic 11Myeloid 10CNS 5Plasma cell 4Head & Neck 4NET 3Endocrine 3Tumor-Agnostic 2Sarcoma 2Dermatologic 2Classical hematology 2Other 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Stomatitis 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Mucositis 1Mouth Neoplasms 1Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Cisplatin 98pembrolizumab 79Radiotherapy 49Carboplatin 41Magnetic Resonance Spectroscopy 37toripalimab 34Radiotherapy, Intensity-Modulated 34Gemcitabine 29Docetaxel 28Cetuximab 28Specimen Handling 26Surgical Procedures, Operative 23Paclitaxel 23Fluorouracil 22Radiation 20Nivolumab 20Biopsy 18Drug Therapy 17Chemoradiotherapy 17Blood Specimen Collection 17Capecitabine 15Surveys and Questionnaires 14Standard of Care 14tislelizumab 13Platinum 13camrelizumab 12nimotuzumab 11Immune Checkpoint Inhibitors 11130-nm albumin-bound paclitaxel 111,2-diaminocyclohexaneplatinum II citrate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Injections × Head & Neck × Clear all
NCT06997094 2026-01-26

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Mayo Clinic

Phase 1 Recruiting
24 enrolled
Head & Neck

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma

NCT07348211 2026-01-23

SIM0610-101

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting
260 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT05966194 2024-11-15

KEVLARx

EpicentRx, Inc.

Phase 2 Recruiting
216 enrolled
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT06022757 2024-02-23

KEYNOTE F19

Evopoint Biosciences Inc.

Phase 1/2 Recruiting
204 enrolled
GenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡